FCDL Comment:
MR1: The dollars requested were reduced to remove: the ineligible products: AP9630 ($14,527.00 OTC), WCS-ENT-PLUS-2500 ($75,913.83 OTC), and 8 spare AP ($4,258.60). <><><><><> MR2: The FRN was modified from $6,075,860.07 OTC to $5,981,160.64 OTC to agree with the applicant documentation.